Radiation responsive PROTAC nanoparticles for tumor-specific proteolysis enhanced radiotherapy

Proteolysis Degradation
DOI: 10.1039/d3tb03046f Publication Date: 2024-02-21T04:01:01Z
ABSTRACT
Proteolysis targeting chimeras (PROTACs) is a promising strategy for cancer therapy. However, the always-on bioactivity of PROTACs may lead to non-target toxicity, which restricts their antitumor performance. Here, we developed an X-ray radiation responsive PROTAC nanomicelle (RCNprotac) by covalently conjugating reported small molecule (MZ1) hydrophilic PEG
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (9)